ELV | Elevance HealthNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$413.75
+$0.15 (+0.04%)

Elevance Health (ELV) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat above the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $413.75 vs 50 $411.05 / 200 $372.70
Projection
No cross projected
Test
No active test
Last cross
Golden cross 20 May 2026 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $420.07 vs 50 $369.05 / 200 $425.23
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
between the two $413.75 vs 50 $417.37 / 200 $403.04
Projection
No cross projected
Test
No active test
Last cross
Golden cross 6 May 2026 ยท projected 28 bars out

Cross history

16
crosses on record since 2023
9 golden7 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
20 May 2026Golden steepdaily26 bars outNot tested
6 May 2026Golden4-hour28 bars outNot tested
20 Mar 2026Death steepdaily27 bars outNot tested
25 Feb 2026Death4-hour18 bars outNot tested
28 Jan 2026Golden moderatedaily29 bars out7 bar cross test

About ELV

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$457M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.